Gastroesophageal Reflux Disease and Coronary Heart Disease - From Pathophysiology to Treatment Controversies

被引:0
|
作者
Floria, Mariana [1 ,2 ]
Barboi, Oana [1 ,3 ]
Bocinca, Cristina [1 ]
Cijevschi-Prelipcean, Cristina [1 ,3 ]
Balan, Gheaorghe [1 ,3 ]
Drug, Vasile Liviu [1 ,3 ]
机构
[1] Grigore T Popa Univ Med & Pharm Iasi, Iasi, Romania
[2] Sf Spiridon Univ Hosp Iasi, Med Clin 3, Iasi, Romania
[3] Sf Spiridon Univ Hosp Iasi, Hepatol & Gastroenterol Inst, Iasi, Romania
关键词
Gastro-oesophageal reflux disease; sympatho-vagal balance; oesophageal-cardiac reflex; PROTON PUMP INHIBITORS; ATRIAL-FIBRILLATION; LINKED ANGINA; ARTERY DISEASE; ASSOCIATION; MECHANISM; RISK;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chest pain experienced by patients with coronary heart disease (CHD) can be of non-cardiac origin, and symptoms frequently related to gastro-oesophageal aetiologies. Gastro-oesophageal reflux disease (GERD) and CHD can cause chest pain and frequently co-exist. It seems that GERD is a frequent condition in patients with CHD. Coexistence of GERD may predispose to the myocardial ischemia. In humans, chemical, electrical, and mechanical stimulation of the oesophagus modifies the sympatho-vagal balance. Gastro-oesophageal reflux disease may cause the shift of sympatho-vagal balance towards its parasympathetic component. One of potential mechanisms explaining the influence of oesophageal disturbance on the appearance of coronary hypo-perfusion may be their common neurological control of the functions, which include oesophageal-cardiac reflex. Short-term proton pump inhibitors therapy in patients with GERD that restores normal oesophageal pH significantly reduces myocardial ischemia, possibly due to elimination of acid-derived oesophageal-cardiac reflex compromising coronary perfusion. Long-term proton pump inhibitors interfere with the clearance of asymmetrical dimethyl-arginine, the endogenous antagonist of nitric oxide synthase. However, mechanisms by which the proton pump inhibitors may increase the risk of major adverse cardiovascular events in CHD patients are still controversial.
引用
收藏
页码:60 / 64
页数:5
相关论文
共 50 条
  • [1] Gastroesophageal reflux disease:From pathophysiology to treatment
    Fernando A Herbella
    Marco G Patti
    World Journal of Gastroenterology, 2010, 16 (30) : 3745 - 3749
  • [2] Gastroesophageal reflux disease: From pathophysiology to treatment
    Herbella, Fernando A.
    Patti, Marco G.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (30) : 3745 - 3749
  • [3] Pathophysiology, diagnosis, and treatment of gastroesophageal reflux disease
    Boeckxstaens, GE
    Tytgat, GNJ
    CURRENT OPINION IN GASTROENTEROLOGY, 1996, 12 (04) : 365 - 372
  • [4] Pathophysiology and medical treatment of gastroesophageal reflux disease
    Corinaldesi, R
    Barbara, G
    Salvioli, B
    Cogliandro, L
    Cogliandro, R
    De Giorgio, R
    Stanghellini, V
    2ND INTERNATIONAL CONGRESS OF THORAX SURGERY, 1998, : 175 - 178
  • [5] Pathophysiology and pharmacological treatment of gastroesophageal reflux disease
    Storr, M
    Meining, A
    Allescher, HD
    DIGESTIVE DISEASES, 2000, 18 (02) : 93 - 102
  • [6] Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Treatment
    Chen, Jingtao
    Brady, Patrick
    GASTROENTEROLOGY NURSING, 2019, 42 (01) : 20 - 28
  • [7] Gastroesophageal reflux disease in the obese: Pathophysiology and treatment
    Nadaleto, Barbara F.
    Herbella, Fernando A. M.
    Patti, Marco G.
    SURGERY, 2016, 159 (02) : 475 - 486
  • [8] PATHOPHYSIOLOGY OF GASTROESOPHAGEAL REFLUX DISEASE
    TIMMER, R
    BREUMELHOF, R
    NADORP, JHSM
    SMOUT, AJPM
    NETHERLANDS JOURNAL OF MEDICINE, 1994, 44 (01): : 1 - 4
  • [9] Pathophysiology of gastroesophageal reflux disease
    Fein, M
    Tigges, H
    Maroske, J
    Freys, SM
    Fuchs, KH
    CHIRURGISCHE GASTROENTEROLOGIE, 2001, 17 (01): : 8 - 13
  • [10] Pathophysiology of gastroesophageal reflux disease
    Lee, Yeong Yeh
    McColl, Kenneth E. L.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2013, 27 (03) : 339 - 351